Bio Developments

MenQuadfi has been approved in Europe, following FDA approval in April this year. Pic:getty/ezumeimages.

European Commission approves Sanofi’s MenQuadfi

By Rachel Arthur

Sanofi’s MenQuadfi becomes the first quadrivalent meningococcal conjugate vaccine available in Europe in a fully liquid presentation, avoiding the need for vaccine reconstitution.

Pic:getty/alishahgholi

A big week for mRNA COVID-19 vaccines: Five key developments

By Rachel Arthur

It’s been a big week for mRNA-based COVID-19 vaccines: with both Pfizer/BioNTech and Moderna reporting impressive efficacy for their COVID-19 vaccine candidates. Here's five key takeaways from this week's developments.

Follow us

Products

View more

Webinars